Trilo Therapeutics is a seed-stage company focused on the discovery of best-in-class ADCs/peptide-drug conjugates for oncology. Our mirror-image peptidomimetics penetrate quickly into tumors and saturate the malignant cells, deliver ultra-potent chemotherapy (or radiotherapy), then rapidly clear the patient's body to minimize toxicity.
| Website | http://www.trilotherapeutics.com |
| Employees | 3 (1 on RocketReach) |
| Founded | 2017 |
| Address | 953 Indiana St, San Francisco, California 94107, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+7 more
(view full list)
|
| Industry | Biotechnology |
| Keywords | Oncology Therapeutics, Antibody Drug Conjugates, Targeted Cancer Therapy, Cancer Drug Development, Cancer Treatment Research, Immuno Oncology, Oncology Research, Clinical Stage Oncology, Tumor Targeting, Biopharmaceutical Research, Therapeutic Antibodies, Precision Oncology, Novel Drug Discovery, Drug Development, Pharmaceutical Research, Next Generation Therapeutics, Biotechnology |
Looking for a particular Trilo Therapeutics employee's phone or email?
Pierre Pujol is the Chief Business Officer of Trilo Therapeutics.
1 people are employed at Trilo Therapeutics.
Trilo Therapeutics is based in San Francisco, California.